Novo Nordisk defends disappointing next gen obesity drug: 'It will be an important product' NBC Connecticut VisualAbstract: Cagrilintide Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes 2 Minute Medicine Novo Nordisk's CagriSema Falls Short in Head to Head Trial vs Zepbound Bryce Platt, PharmD posted on the topic LinkedIn Cagrilintide: What It Is and How It's Being Studied for Weight Loss CagriSema Yields Nearly 16% Weight Loss in Phase 3 REDEFINE 2 Trial HCPLive